We are aware of an ongoing issue preventing users from accessing ChemDraw due to licensing limitations. At present, we are unable to extend licence availability or implement a long-term fix while discussions continue with the supplier (Revvity).

We apologise for the disruption this is causing and will provide an update once a workable solution has been identified.